145 related articles for article (PubMed ID: 24002926)
1. Application of artificial neural networks for optimization of preparation of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan.
Shahsavari Sh; Bagheri G; Mahjub R; Bagheri R; Radmehr M; Rafiee-Tehrani M; Dorkoosh FA
Drug Res (Stuttg); 2014 Mar; 64(3):151-8. PubMed ID: 24002926
[TBL] [Abstract][Full Text] [Related]
2. Application of Artificial Neural Networks in the Design and Optimization of a Nanoparticulate Fingolimod Delivery System Based on Biodegradable Poly(3-Hydroxybutyrate-Co-3-Hydroxyvalerate).
Shahsavari S; Rezaie Shirmard L; Amini M; Abedin Dokoosh F
J Pharm Sci; 2017 Jan; 106(1):176-182. PubMed ID: 27666377
[TBL] [Abstract][Full Text] [Related]
3. Preparation, statistical optimization, and in vitro characterization of insulin nanoparticles composed of quaternized aromatic derivatives of chitosan.
Mahjub R; Dorkoosh FA; Amini M; Khoshayand MR; Rafiee-Tehrani M
AAPS PharmSciTech; 2011 Dec; 12(4):1407-19. PubMed ID: 22033812
[TBL] [Abstract][Full Text] [Related]
4. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
5. Performance comparison of neural network training algorithms in modeling of bimodal drug delivery.
Ghaffari A; Abdollahi H; Khoshayand MR; Bozchalooi IS; Dadgar A; Rafiee-Tehrani M
Int J Pharm; 2006 Dec; 327(1-2):126-38. PubMed ID: 16959449
[TBL] [Abstract][Full Text] [Related]
6. Effects of processing parameters on particle size of ultrasound prepared chitosan nanoparticles: an Artificial Neural Networks Study.
Esmaeilzadeh-Gharedaghi E; Faramarzi MA; Amini MA; Rouholamini Najafabadi A; Rezayat SM; Amani A
Pharm Dev Technol; 2012; 17(5):638-47. PubMed ID: 22681416
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives.
Bayat A; Larijani B; Ahmadian S; Junginger HE; Rafiee-Tehrani M
Nanomedicine; 2008 Jun; 4(2):115-20. PubMed ID: 18339584
[TBL] [Abstract][Full Text] [Related]
9. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
[TBL] [Abstract][Full Text] [Related]
10. Design, characterization and ex vivo evaluation of chitosan film integrating of insulin nanoparticles composed of thiolated chitosan derivative for buccal delivery of insulin.
Mortazavian E; Dorkoosh FA; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 May; 40(5):691-8. PubMed ID: 24524272
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods.
Sadeghi AM; Dorkoosh FA; Avadi MR; Saadat P; Rafiee-Tehrani M; Junginger HE
Int J Pharm; 2008 May; 355(1-2):299-306. PubMed ID: 18206322
[TBL] [Abstract][Full Text] [Related]
12. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
Lin CC; Lin CW
Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
[TBL] [Abstract][Full Text] [Related]
13. Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology.
Li Y; Abbaspour MR; Grootendorst PV; Rauth AM; Wu XY
Eur J Pharm Biopharm; 2015 Aug; 94():170-9. PubMed ID: 25986587
[TBL] [Abstract][Full Text] [Related]
14. Processing/formulation parameters determining dispersity of chitosan particles: an ANNs study.
Esmaeilzadeh-Gharehdaghi E; Faramarzi MA; Amini MA; Moazeni E; Amani A
J Microencapsul; 2014; 31(1):77-85. PubMed ID: 23795904
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of chitosan/streptokinase nanoparticles as a function of size: An artificial neural networks study.
Baharifar H; Amani A
Nanomedicine; 2016 Jan; 12(1):171-80. PubMed ID: 26409193
[TBL] [Abstract][Full Text] [Related]
16. The use of artificial neural network (ANN) for modeling of COD removal from antibiotic aqueous solution by the Fenton process.
Elmolla ES; Chaudhuri M; Eltoukhy MM
J Hazard Mater; 2010 Jul; 179(1-3):127-34. PubMed ID: 20307930
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
18. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
